HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 39, 36373-36379, September 27, 2002

This Article Abstract Full Text (PDF) All Versions of this Article: 277/39/36373    most recent M205479200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, R. Articles by Eckenhoff, R. G. Search for Related Content PubMed PubMed Citation Articles by Liu, R. Articles by Eckenhoff, R. G. Social Bookmarking                      What's this?

The Role of Electrostatic Interactions in Human Serum Albumin Binding and Stabilization by Halothane^*

Renyu Liu^§, Ravindernath Pidikiti, Chung-Eun Ha^¶, Charles E. Petersen^¶, Nadhipuram V. Bhagavan^¶, and Roderic G. Eckenhoff

From the  Department of Anesthesia, University of Pennsylvania, Philadelphia, Pennsylvania 19104-4283 and ^¶ Department of Biochemistry and Biophysics, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii 96822

Received for publication, June 3, 2002, and in revised form, July 9, 2002

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Electrostatic interactions have been proposed as a potentially important force for anesthetics and protein binding but have not yet been tested directly. In the present study, we used wild-type human serum albumin (HSA) and specific site-directed mutants as a native protein model to investigate the role of electrostatic interactions in halothane binding. Structural geometry analysis of the HSA-halothane complex predicted an absence of significant electrostatic interactions, and direct binding (tryptophan fluorescence and zonal elution chromatography) and stability experiments (hydrogen exchange) confirmed that loss of charge in the binding sites, by charged to uncharged mutations and by changing ionic strength of the buffer, generally increased both regional (tryptophan region) and global halothane/HSA affinity. The results indicate that electrostatic interactions (full charges) either do not contribute or diminish halothane binding to HSA, leaving only the more general hydrophobic and van der Waals forces as the major contributors to the binding interaction.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Inhalational anesthetics can alter the activity of a wide variety of proteins, but the molecular nature of the interactions underlying the functional effect is still poorly understood. Guided by the Meyer-Overton correlation between anesthetic potency and solubility in a lipid-like environment, studies in the past three decades have concluded that anesthetics must bind to hydrophobic regions within target protein (especially membrane protein, i.e. ion channels) through weak van der Waals interactions and the hydrophobic effect (1-5). Electrostatic interactions were proposed recently as potentially important binding forces between anesthetics and target proteins (1, 6, 7).

Halogen atoms, especially fluorine, are more electronegative than carbon atoms, and therefore the C-halogen bond is polarized in inhalational anesthetics. Ab initio calculations indicated that halothane has a small permanent dipole moment (8), which may contribute binding to relevant targets. Similar compounds with less dipole than halothane are poor anesthetics, although this might be partially due to much lower solubility in water (1). Because polarity appears to be an important feature of anesthetics, it is reasonable to speculate that anesthetic binding sites contain polar moieties. Charged residues such as arginine and lysine and polar but uncharged aromatic groups with a partial negative charge in the center of the ring (9, 10) may contribute to the polarity of anesthetic binding sites. The weakly polar anesthetics might therefore interact with the charged residues directly and/or form dipole-quadrupole (a form of weak cation-) interactions with the aromatic side chains. The latter may be strengthened by the positively charged residues coordinating the more electronegative end of the anesthetic molecule.

Because functionally important anesthetic targets remain unidentified, we have made use of surrogate proteins with appropriate binding character (1, 11-14). Designed peptides, for example, have been used to investigate the halothane binding site and its characteristics. In a synthetic four-helix-bundle protein, substitution of tyrosine for tryptophan decreased anesthetic binding affinity by about 5-fold, suggesting that the less dense electron cloud of tyrosine coordinates the relatively positive end of the anesthetic molecule less well (14). In the present study, we have used human serum albumin (HSA)¹ as a native protein model to investigate electrostatic interactions directly. HSA is useful because it satisfies major pharmacodynamic criteria for simulating the anesthetic targets (11) and has a binding affinity for halothane within 10-fold of its clinical EC₅₀, and a high resolution structure of HSA alone and in complex with halothane is now available (15). We focused on a large interdomain cavity containing the only tryptophan in HSA in this study. Previous work has confirmed that anesthetics bind to this region (12, 16), which also contains many charged residues (15, 17). If the relatively positive end of halothane coordinates with the  system of the tryptophan indole ring in a weak cation- interaction, then it is possible that nearby positively charged residues may coordinate the relatively negative trifluoromethyl end of halothane (1). We predict that loss of positively charged side chains near Trp will eliminate an electrostatic contribution to halothane binding and therefore weaken halothane-HSA binding constants. To test this, we performed geometrical analysis of HSA (1E78) and the HSA-halothane complex structures (1E7B and 1E7C), expressed nine site-directed HSA mutants, and tested these for altered halothane binding using fluorescence spectroscopy, zonal elution chromatography, and amide hydrogen exchange combined with ionic strength experiments.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Materials

Halothane (1-bromo-1-chloro-2,2,2-trifluoroethane) was obtained from Halocarbon Laboratories (Hackensack, NJ). The thymol preservative and water in halothane were removed before use with an aluminum oxide column. [³H]OH was obtained from ICN (Costa Mesa, CA) at 100 mCi/ml. All other chemicals were reagent grade or better and were obtained from Sigma.

Expression and Purification of Recombinant HSA

Recombinant wild-type HSA (wtHSA) and nine HSA mutants were expressed in a yeast expression system. Seven single mutants (K195M, K199M, R218M, R218P, R218H, R222M, and R257M) of HSA replaced positively charged residues with uncharged ones, one single mutant (H242V) replaced an uncharged polar residue with an uncharged nonpolar residue, and one single mutant (F211V) replaced an aromatic residue with an uncharged, nonpolar residue. All of the replaced residues are within 15 Å from C₃ of W214 in 1E78 (Table I; Fig. 1A) and the known halothane binding sites (halothane 2005 and halothane 2006) in 1E7C (Fig. 1B) (15). We chose these residues because each lines the tryptophan cavity (15), and our previous fluorescence and photolabeling data showed that halothane binds in close proximity to W214 (12, 13, 16).

View larger version (42K): [in this window] [in a new window]   Fig. 1.   Mutated residues around the Trp (W214) binding site in HSA from 1E78 (A) and 1E7C with two halothane molecules (B). HLT5 and HLT6 represent halothane 2005 and halothane 2006 in 1E7C. Dotted lines are possible hydrogen bonds between residues. Nitrogen atoms are shown in dark red. Oxygen atoms are shown in dark blue. Halogen atoms are shown in yellow.

Cloning of HSA Coding Region-- With human liver cDNA as a template, the entire coding region of the HSA gene, including the native signal sequence, was amplified by the polymerase chain reaction using Vent DNA polymerase (New England Biolabs). The resulting DNA fragment was inserted into the plasmid vector pHiL-D2 (Invitrogen) using standard cloning techniques. pHiL-D2 is a shuttle vector that can be manipulated by cloning in Escherichia coli and can also be used to introduce genes into the yeast species Pichia pastoris (Invitrogen) by homologous recombination. Specific mutations were introduced into the HSA coding region using site-directed mutagenesis (18).

Expression of Recombinant HSA-- Each pHiL-D2 expression plasmid contained a methanol-inducible promoter located upstream of the HSA coding region. For each expression plasmid, a yeast clone that contained the expression cassette stably integrated into the yeast chromosomal DNA was isolated. The native HSA signal sequence, which was introduced into the yeast genome with the HSA coding region, directed a high level secretion of mature HSA into the growth medium.

Verification of DNA Sequence of HSA Clones-- The total genomic DNA from each P. pastoris clone used to produce a particular HSA species was isolated using standard techniques. The genomic DNA isolated from each clone was used as a template to amplify the entire HSA coding region by the polymerase chain reaction. For each clone, the entire HSA coding region was sequenced using the dideoxy chain termination technique, and the determined DNA sequence matched a previously published cDNA sequence of HSA at all amino acid positions except for the mutation introduced into a particular HSA variant.

Purification of Recombinant HSA-- The secreted HSA was isolated from the growth medium as follows. The medium was brought to 50% saturation with ammonium sulfate at room temperature. The temperature was then lowered to 4 °C, and the pH was adjusted to 4.4, the isoelectric point of HSA. The precipitated protein was collected by centrifugation and resuspended in distilled water. Dialysis was carried out for 48 h at 4 °C against 100 volumes of distilled water, followed by 24 h against 100 volumes of phosphate-buffered saline (150 mM NaCl and 40 mM phosphate, pH 7.4). The solution was loaded onto a column of Cibacron blue immobilized on Sepharose 6B (Sigma). After washing the column with 10 bed volumes of phosphate-buffered saline, the HSA was eluted with 3 M NaCl. The eluent was dialyzed into phosphate-buffered saline and passed over a column of Lipidx-1000 (Packard Instruments) to remove hydrophobic ligands possibly bound to the HSA. The resulting protein migrated as a single band on SDS-polyacrylamide gel electrophoresis.

Structural Geometry Analysis

Atomic coordinates of HSA (1E78) and the HSA-halothane complex (1E7B and 1E7C) (15) were obtained from the Protein Data Bank (www.rcsb.org/pdb). Atomic distances were calculated with Swiss-PDB Viewer (v3.7 2; www.expasy.ch). Potential cation- interactions were identified with CaPTURE (capture.caltech.edu) (10).

Regional Binding Measurements

Quenching of Trp fluorescence was used to study halothane-HSA regional binding as described previously (16). Briefly, halothane was dissolved in the phosphate buffer to a concentration of 10 mM and loaded into a gas-tight Hamilton syringe. Different concentrations of halothane were equilibrated with 1 mM wtHSA (or mutants) in a quartz cell during fluorescence measurements. The point of 50% inhibition (IC₅₀) of the fluorescence maxima in halothane-free species was calculated (12, 16) with Hill plots. The buffer used for fluorescence experimentation was 130 mM sodium chloride, 20 mM sodium phosphate, pH 7.0.

Fluorescence measurements were performed with a Fluorescence Spectrophotometer RF-5301PC (Shimadzu, Columbia, MD). A 10-mm-pathlength quartz cell (1.5 ml) with a polytetrafluorethylene stopper was used without much difference in air pockets. All fluorescence measurements were made at room temperature (25 ± 1 °C). Excitation and emission slit widths were 3 and 5 nm, respectively. The background fluorescence was subtracted from each emission spectrum. All HSA mutants have Trp at the 214 position, which is located in subdomain IIA, one of the binding sites for aromatic and heterocyclic compounds. The single tryptophan was excited at a wavelength of 295 nm, and emission spectra were recorded from 310 nm to 450 nm for all HSA mutants.

In addition to the above halothane titrations, we also examined the influence of ionic strength on halothane binding to wtHSA. Thus, a halothane EC₅₀ was calculated for titrations performed in 20 mM sodium phosphate buffer containing 0, 130, or 500 mM sodium chloride.

Global Binding Measurements

Zonal elution chromatography was used to study halothane-HSA global binding as we described previously (19). Briefly, 3 ml of Af-fiGel 10 was washed in cold distilled water and transferred to a graduated cylinder. Excess water was removed, and coupling was accomplished by adding 2.5 ml of the HSA solution (50 mg/ml) and gently mixing. After coupling for 2 h at room temperature, the gel was allowed to settle, and the supernatant was removed. To block all remaining unreacted groups, the gel was then incubated with 0.3 M glycine, pH 7.0, for an additional 30 min. A control gel was prepared by reacting 3.0 ml of 0.3 M glycine, pH 7.0, with 3.0 ml of gel for 2 h as described above. Aliquots of the pre- and postcoupling solutions were saved to determine the immobilized mass. Protein assays were performed with the Bio-Rad reagent. The coupled gel was washed with degassed mobile phase (10 mM NaPO₄, pH 7.0) and packed into Bio-Rad MT-2 columns (holding about 2.0 ml of gel). Columns were connected to a Shimadzu LC-600 Liquid Chromatograph pump and then flushed with mobile phase at 0.4 ml/min until a steady baseline, as detected by UV absorbance at 210 nm (Shimadzu SPD-6AV), was established.

With the apparatus running at 0.4 ml/min, the column was equilibrated with 10 mM sodium phosphate buffer containing either 0, 130, or 500 mM NaCl. Small (50 µl) aliquots of 10 mM halothane in the same mobile phase were injected (t = 0), and absorbance (210 nm) was monitored for 20 min. Retention times for the halothane peaks from the different sodium chloride concentrations and for the different columns (HSA and glycine) were compared.

Hydrogen-Tritium Exchange

Changes in ligand binding should be reflected in changes in protein stability, and amide hydrogen exchange is the most sensitive method of measuring these changes (15). Protein solutions (1 mg/ml) were incubated with 5-10 mCi of [³H]OH in 1 M GdnCl, 0.1 M NaH₂PO₄ buffer, pH 8.5, for at least 18 h at room temperature for exchange-in. Free [³H]OH was removed, and the buffer was exchanged with a PD-10 gel filtration column (Sigma), thereby initiating exchange-out with 0.5 M GdnCl, 0.1 M NaH₂PO₄ buffer, pH 7.4. After recovery from the column, the protein solution was immediately transferred to prefilled Hamilton (Reno, NV) gas-tight syringes containing 7.0 mM halothane in exchange-out buffer and equipped with repeaters. Aliquots were precipitated with 2 ml of ice-cold 20% trichloroacetic acid at timed intervals over at least 6 h. The precipitated protein was rapidly vacuum-filtered through Whatman GF/B filters and washed with 8 ml of ice-cold 2% trichloroacetic acid. ³H retained by the protein was determined by liquid scintillation counting. Exchange-out buffer conditions were adjusted to focus on the last 5-10% of hydrogens over a 6-h period to ensure that global unfolding events were being monitored.

Protection factors ratio (PFr) for given hydrogens was determined from the exchange-out curves as described previously (11). The changes of free energy change (G) were determined (G = RTln(PFr). Negative values reflect stabilization (slower exchange out).

The influence of ionic strength on halothane stabilization to wtHSA was studied in 10 mM sodium phosphate buffer, obtaining different ionic strengths by including the requisite amounts of NaCl (0 and 500 mM) in the exchange-out buffer.

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Structural Geometry Analysis-- We focused on halothane 2005 and 2006 in 1E7C because these two molecules are the closest to W214. Using distance analysis, we found that halothane does not have any orientation preference to any of the mutated residues (Table II). The closest charged residue from halothane 2005 is R257. The nearest atoms are the O of arginine and the Cl of halothane (3.6 Å). The closest charged residues from halothane 2006 are R218 and R222. In this case, the nearest atoms are C and Cl (3.1 Å) between R218 and halothane, respectively, and N and F (3.7 Å) between R222 and halothane, respectively. Only this latter N-F (3.7 Å) interaction between R222 and halothane 2006 could indicate an attractive electrostatic interaction.

CaPTURE detected eight energetically significant cation- interactions in 1E78, 1E7B (with 3 halothane molecules), and 1E7C (with 8 halothane molecules) (Table III). None of these were between halothane and HSA. Both 2005 and 2006 halothane molecules point to the tryptophan ring with their relatively negative end (trifluoromethyl end; Table IV). Although the total number of cation- interactions was preserved in the HSA-halothane complex, the distribution was different than in HSA alone. For example, the K199-W214 interaction is not present in 1E7C.

View this table: [in this window] [in a new window]   Table III Energetically significant cation- interactions in HSA model

Effect on Fluorescence Quenching of Mutations-- With 295 nm excitation, the wavelength of maximum fluorescence emission is 339 nm in wtHSA, and ranges from 338 to 340 nm in all mutants except K195M (341 nm) and R218P (343 nm). The IC₅₀ for halothane quenching of wtHSA fluorescence was 2.9 ± 0.1 mM. The charged to uncharged mutations (K195M, K199M, R218M, R222M, and R257M) generally decreased the IC₅₀ of halothane by 10-35%, indicating improvement in halothane binding in this W214 binding site. H242V also decreased IC₅₀. The deletion of one aromatic ring-containing residue (F211V) also decreased the IC₅₀ of halothane (Fig. 2). Only R218P and R218H increased IC₅₀ (weakened binding). The change of the residue volume correlates significantly with the change in IC₅₀ of halothane (Fig. 3); smaller residue substitution (enlarging the cavity) tends to reduce halothane binding affinity.

View larger version (9K): [in this window] [in a new window]   Fig. 2.   Loss of charge generally enhances HSA affinity for halothane. IC50, or the halothane concentration resulting in 50% inhibition of the maximum fluorescence emission, decreased in most of the charged to uncharged mutations. Loss of one aromatic ring (F211V) also enhanced halothane binding. Data are the mean ± S.E., n = 2.

View larger version (15K): [in this window] [in a new window]   Fig. 3.   Cavity volume plays a role in halothane binding. Residue volume difference reflects the wild-type residue volume minus the mutant residue volume. Because all the mutations in the present study are large to small, we assumed cavity volume increased after mutation. A significant correlation (r2 = 0.5, p = 0.03) between residue volume difference and the affinity was revealed by linear regression analysis. IC50 is the halothane concentration resulting in a 50% of inhibition of the maximum fluorescence emission.

Effect on Hydrogen Exchange of Mutations-- Because the mutation may change native state stability, which may affect binding independently of changes in the local environment, we performed hydrogen exchange for global protein stability. These single mutations produced only small or no changes in baseline protein stability as indicated by hydrogen exchange, and the changes are limited to the mutations at position 218. G values are 1.4 ± 0.3 kcal/mol in R218P, 0.4 ± 0.2 kcal/mol in R218H, and 0.5 ± 0.2 kcal/mol in R218M.

Tryptophan fluorescence reports only a local or regional binding interaction of halothane, and it is not clear whether or how this contributes to global stability. Consistent with the tryptophan fluorescence data, hydrogen exchange shows that halothane generally enhances the global protein stability of the charged to uncharged mutants more than that of wtHSA (Fig. 4), suggesting improved specific binding and protein stabilization. Better stabilization also was observed in F211V. Despite consistency of the direction of change, there was no significant correlation between halothane IC₅₀ and G (Fig. 5).

View larger version (17K): [in this window] [in a new window]   Fig. 4.   Loss of charge results in better stabilization by halothane. Only in R257M did halothane cause a slight decrease in stability relative to wtHSA. G is the change in free energy change produced by 7 mM halothane. Data are the mean ± S.E., n = 2.

View larger version (13K): [in this window] [in a new window]   Fig. 5.   No significant correlation between regional (domain IIA) binding (IC50) of halothane and the global stability change (G) by halothane was found. IC50 is the halothane concentration resulting in a 50% of inhibition of the maximum fluorescence emission. G is the change in free energy change produced by 7 mM halothane. The line represents a least squares linear regression.

Ionic Strength Effects on Binding and Stability-- The halothane IC₅₀ from fluorescence experiments decreased from 4.1 ± 0.1 mM in the absence of NaCl, to 2.9 ± 0.1 mM in the presence of 130 mM NaCl and to 2.4 ± 0.3 mM in the presence of 500 mM NaCl (Fig. 6). These results indicate that with the increase of ionic strength, the affinity of HSA for halothane increased rather than decreased.

View larger version (18K): [in this window] [in a new window]   Fig. 6.   The effect of ionic strength on regional binding (domain IIA) of wtHSA. With the increase of ionic strength, the concentration-effect curve was shifted to the left. The IC50 decreased from 4.1 ± 0.1 mM in the absence of NaCl to 2.9 ± 0.1 mM in the presence of 130 mM NaCl and to 2.4 ± 0.3 mM in the presence of 500 mM NaCl. IC50 is the halothane concentration resulting in a 50% of inhibition of the maximum fluorescence emission. IC50s are represented as the mean ± S.E., n = 2.

From the zonal elution chromatography experiments, the retention time for halothane became more prolonged with the increase of the NaCl concentration (6.27 min in 0 mM NaCl, 6.43 min in 130 mM NaCl, and 6.77 min in 500 mM NaCl) (Fig. 7). The retention time for halothane in the control column was significantly shorter (5.3 min) than that in the HSA column and did not change with the increase of NaCl concentration.

View larger version (16K): [in this window] [in a new window]   Fig. 7.   The effect of ionic strength on the global binding of wtHSA to halothane. The retention time for halothane was prolonged with increasing NaCl concentration: 6.27 min in 0 mM NaCl (HSA0 curve), 6.43 min in 130 mM NaCl (HSA130 curve), and 6.77 min in 500 mM NaCl (HSA500 curve). The retention time for halothane in the control column was significantly shorter (5.3 min) than that in the HSA column and did not change with increasing NaCl concentration. For simplicity, only one curve from the glycine control column is presented because the curves from different salt concentration overlap.

The hydrogen exchange experiment shows that NaCl alone stabilized HSA, but additional stabilization by halothane in the different NaCl concentrations could not be detected (Fig. 8).

View larger version (17K): [in this window] [in a new window]   Fig. 8.   The effect of ionic strength on the global stability of wtHSA. NaCl increased wtHSA stability (G = 0.4 kcal/mol); however, the effect of halothane on wtHSA stability did not change. G is 1.0 kcal/mol in the presence of halothane and 0 mM NaCl (Halo-no-NaCl versus Control-no-NaCl). G is 1.0 kcal/mol in the presence of halothane and 500 mM NaCl (Halo-NaCl-500 mM versus Control-NaCl-500 mM). G is the change in free energy change produced by 7 mM halothane. Halo, halothane.

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

The polar aspect of anesthetic binding sites has been stressed many times previously (1, 6, 7, 20-23) but has not been the subject of direct testing. Contrary to our initial prediction, the charged to uncharged mutation in the W214 region of HSA generally strengthened halothane binding and stabilization. Furthermore, the increase in ionic strength also enhanced both regional and global binding, and, finally, geometric analysis of high resolution structures of the halothane-HSA complex failed to provide evidence of significant electrostatic interactions in the tryptophan binding site. These results are consistent in indicating that electrostatic interactions do not enhance HSA-halothane binding. In fact, these data would suggest that electrostatic features in this cavity actually hinder halothane binding. If this binding site shares similarity with sites on functionally relevant proteins, our results suggest that binding of halothane and probably other inhaled anesthetics is controlled primary by the more general hydrophobic and van der Waals forces.

Selectivity/Specificity

Specificity to ligand protein interactions is achieved by a multiplicity of features, namely electrostatic, van der Waals, hydrophobic, and steric effects. These factors contribute toward selective and energetic binding interactions. In a folded protein, the arrangement of positively and negatively charged residues causes a considerable variation in the electrostatic potential throughout the protein. This provides, at specific sites, significant electrostatic contributions to the free energy of binding of the ligand. For example, a major binding force between indomethacin and HSA is electrostatic in nature (24). Our finding that electrostatic interactions do not contribute to halothane binding in a natural and pharmacodynamically relevant protein model leaves only the other noncovalent interactions to contribute to the binding free energy. This results in low binding affinity, as shown here, and also reduces the specificity and selectivity of binding sites. This paucity of interactions suggests that many targets of comparable anesthetic binding affinity are more likely than a few high affinity targets.

Electrostatic Interactions

Full Charge Separation-- Structure geometrical analysis revealed an absence of direct positive and negative electrostatic interactions between halothane and the charged residues of HSA. Consistent with this, our fluorescence results showed that halothane affinity is enhanced by charged to uncharged mutations, suggesting that electrostatic interactions did not contribute to HSA-halothane binding but actually hindered the binding interaction. This is also consistent with previous potency correlative analysis (21). However, this conclusion must be tempered by the fact that the investigated site is complex and has several fully charged lining residues. Thus, we cannot be certain that removing a single charge at a time will not strengthen a potential electrostatic interaction with another, unaltered residue or enhance the cavity polarity in a favorable way. We think this is unlikely because a charged to uncharged mutation enhanced binding in every one of the seven positions and because geometric analysis of the HSA-halothane complex did not reveal any significant electrostatic pairs. Nevertheless, this does not eliminate a role for weak polar effects (partial charges and polarizable atoms). Small organic molecules that have anesthetic properties generally have a modest dipole moment or are polarizable; thus, it is likely that the binding environments for these compounds have a complementary polar nature.

Although a charged to uncharged mutation enhanced halothane binding at every position investigated, not all such mutations had this effect. For example, whereas R218M enhanced binding, R218H and R218P decreased halothane binding somewhat. This may be explained by other effects of these less common residues. For example, whereas histidine is essentially uncharged at physiologic pH, it is nevertheless polar, bulky, and less flexible than arginine. Similarly, proline is rigid and is known to distort secondary and perhaps tertiary structure. This is consistent with the large effect of R218P on native state stability and a small red shift of the maximum fluorescence emission. Thus, it is likely that the apparent inconsistency of these two mutations at position 218 is due to unintended steric effects. Without crystal structures for each mutant, this conclusion must remain tentative.

Increases in ionic strength should "screen" charges in water-accessible sites and reduce their effect on ligand binding in a competitive way. Thus, if electrostatic interactions were important, an increase in ionic strength should reduce their contribution to binding free energy and thus weaken binding. Instead, we found that an increase in ionic strength strengthened binding. Increased ionic strength also stabilized HSA as shown by hydrogen exchange, but this did not alter the degree of stabilization produced by halothane. Taken together, the ionic strength experiments also suggest that electrostatic interactions do not contribute to halothane binding energetics.

Cation- Interactions-- Structure geometry analysis shows that cation- interactions among amino acid residues exist in HSA, and the distribution of cation- interactions is altered in the HSA-halothane complex. Although this might be due to competitive interactions between native cation- and halothane, our inability to detect any cation- interaction between any halothane atom and a protein atom makes this unlikely. Furthermore, replacing one aromatic ring in this binding cavity with an aliphatic residue (F211V) also increased halothane binding affinity. Thus, the change in cation- distribution probably reflects a subtle change in protein conformation in the HSA-halothane complex. Our inability to detect an anesthetic-protein cation- interaction in this HSA binding site does not negate the potential importance of such interactions in other sites. Indeed, recent work in designed four-helix bundles suggested a cation- interaction between anesthetics and proteins (14). It might be relevant to note that bulky aromatic residues are more commonly found in internal protein cavities where anesthetics might be expected to bind (25), and thus it is attractive to speculate that cation- interactions contribute to binding in some protein targets.

Other Effects of Mutation

In addition to effects on polarity and charge, the mutations introduce volume and steric effects. If internal protein cavities are attractive binding sites for anesthetics, then volume is important; if the volume is too small, the molecule cannot be accommodated, and if it is too large, van der Waals London forces (which fall off rapidly as a function of distance) will be insufficient to produce binding. Indeed, we found a significant relationship between change in residue volume and IC₅₀, whereby mutations producing little change in cavity volume enhanced affinity, and those increasing cavity volume reduced affinity. Thus, loss of charge appears to improve halothane binding when the change in cavity volume is small, but this is probably offset by loss of van der Waals contacts when volume change is large.

Steric and conformational effects also need to be considered. For example, the slight decrease in halothane affinity in the proline and histidine mutations may relate not only to volume effects but also to the more rigid nature of their side chains. Methionine has considerable conformational entropy and thus may be able to accommodate the ligand in this tryptophan cavity at a lower free energy expense. The same would be true for the smaller aliphatic side chain of valine. Thus, the basis for alterations in affinity with these mutations is likely to be multifactorial.

Global Binding and Stability

Halothane binds to at least 7-10 sites in HSA (12, 15, 16), so clearly mutagenesis of all possible interacting residues would have been prohibitive. Zonal elution chromatography provides an alternative tool to investigate the global weak interaction between anesthetics and proteins (19). Consistent with the mutagenesis and regional binding study, the result indicated that HSA affinity to halothane strengthened with the increase of the salt concentration. These experiments suggest a generality of the binding sites; electrostatic interactions do not appear to be important for binding in the other binding sites of HSA either.

Most proteins are only marginally stable in order to allow the conformational changes that underlie their function. Thus, small changes in native stability may have considerable implications to protein activity and biologic function. A drawback of mutagenesis is that the mutations might disturb the global protein stability significantly and unpredictably. Thus, we considered it is important to evaluate the effects of these mutations on native state stability using amide hydrogen exchange kinetics. Fortunately, the stability change of the mutants in the present study is generally very small and is limited to mutations at the 218 position. R218P, for example, destabilized HSA by over 1 kcal/mol, which alone may have considerable effects on ligand binding and function independent of any regional effects. It is even possible that this large effect on global stability is responsible for the decrease in halothane binding affinity noted with this mutation.

We have previously suggested that anesthetics exert their effects on proteins at the molecular level by regional specific binding and global alterations in conformational stability (11, 12, 26, 27). In agreement with the fluorescence results, the present hydrogen exchange results also indicated that halothane stabilizes almost all the charged to uncharged mutants better than wtHSA, except R257M. The lack of correlation between halothane stabilization (G) and fluorescence quenching (IC₅₀) with the various mutants most likely reflects that the W214 site is only one of many halothane binding sites in this protein (12, 15, 16).

In summary, we used HSA and specific site-directed mutants as a native protein model to investigate the role of electrostatic interactions in halothane binding. Structural geometry analysis of the HSA-halothane complex predicted an absence of significant electrostatic interactions, and direct binding and stability experiments confirmed that loss of charge in the binding site generally increased halothane/HSA affinity. The results all point to the same conclusion: electrostatic (positive and negative) interactions either do not contribute to or diminish halothane binding to HSA, leaving only the more general hydrophobic and van der Waals forces as the major contributors to the binding interaction. An important implication of this study is that if HSA binding sites are similar to functionally relevant targets, then the likelihood of finding highly specific and selective inhalational anesthetic binding sites or targets is low.

	ACKNOWLEDGEMENTS

We are indebted to Dr. Jonas S. Johansson for discussion and review of the manuscript and to Susan S. Lin for expert technical assistance.

	FOOTNOTES

^* This work was supported by NIGMS, National Institutes of Health Grants 51595 and 55876.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^§ To whom correspondence should be addressed: Dept. of Anesthesia, University of Pennsylvania Medical Center, 3400 Spruce St., 7 Dulles, Philadelphia, PA 19104-4283. Tel.: 215-614-0278; Fax: 215-349-5078; E-mail: liu@mail.med.upenn.edu.

Published, JBC Papers in Press, July 12, 2002, DOI 10.1074/jbc.M205479200

	ABBREVIATIONS

The abbreviations used are: HSA, human serum albumin; wtHSA, wild-type HSA.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				T. Seto, H. Isogai, M. Ozaki, and S. Nosaka Noble Gas Binding to Human Serum Albumin Using Docking Simulation: Nonimmobilizers and Anesthetics Bind to Different Sites Anesth. Analg., October 1, 2008; 107(4): 1223 - 1228. [Abstract] [Full Text] [PDF]

				J. H. Streiff, T. W. Allen, E. Atanasova, N. Juranic, S. Macura, A. R. Penheiter, and K. A. Jones Prediction of Volatile Anesthetic Binding Sites in Proteins Biophys. J., November 1, 2006; 91(9): 3405 - 3414. [Abstract] [Full Text] [PDF]

				R. Liu, P. J. Loll, and R. G. Eckenhoff Structural basis for high-affinity volatile anesthetic binding in a natural 4-helix bundle protein FASEB J, April 1, 2005; 19(6): 567 - 576. [Abstract] [Full Text] [PDF]

				D. E. Raines, F. Gioia, R. J. Claycomb, and R. J. Stevens The N-Methyl-D-aspartate Receptor Inhibitory Potencies of Aromatic Inhaled Drugs of Abuse: Evidence for Modulation by Cation-{pi} Interactions J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 14 - 21. [Abstract] [Full Text] [PDF]

				T. A. Binkowski, S. Naghibzadeh, and J. Liang CASTp: Computed Atlas of Surface Topography of proteins Nucleic Acids Res., July 1, 2003; 31(13): 3352 - 3355. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 277/39/36373    most recent M205479200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, R. Articles by Eckenhoff, R. G. Search for Related Content PubMed PubMed Citation